<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04427943</url>
  </required_header>
  <id_info>
    <org_study_id>S-20170108/69984</org_study_id>
    <nct_id>NCT04427943</nct_id>
  </id_info>
  <brief_title>Outcome After Revisions of Infected Knee Arthroplasties</brief_title>
  <acronym>RIKA</acronym>
  <official_title>Outcome After Revisions of Infected Knee Arthroplasties - a Prospective Multicenter Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective multicenter cohort study on all types of revision knee arthroplasty procedures
      performed due to infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective multicenter cohort study on all types of revision knee arthroplasty procedures
      performed due to infection.

      Most previous studies investigating outcomes after revisions of infected knee artrplasties
      are single-center studies and retrospective. The study group has previously investigated
      outcome of the surgical treatment of infected knee arthroplasties in Denmark based on
      nationwide data from Danish registries. These studies revealed that the risk of treatment
      failure causing re-revision or mortality was 30-40% in Denmark.

      Based on these findings, an ongoing randomized controlled trial &quot;one-stage versus two-stage
      revisions of the infected knee arthroplasty&quot; (ClinicalTrials.gov ID: NCT03435679) has been
      initiated by the study group in Febuary 2018. It has been possible to include 20% of the
      patients with surgically demanding periprosthetic knee infections from the including centres
      in this randomized trial due to in- and exclusions criteria. Hence, the investigators wish to
      include the remaining patients with periprosthetic knee joint infection in a prospective
      cohort study in order to obtain high quality prospective data on function, quality of life
      and complications after all types of surgical procedures performed due to periprosthetic knee
      joint infection. Based on these data it will be possible to evaluate the surgical treatment
      overall and it will be possible to evaluate whether the patients included in the randomized
      trial are representative.

      Study aim:

      To present patient reported outcome and postoperative complications after all types of
      surgical procedures performed due to periprosthetic knee infection. Furthermore, to analyze
      the role of potential risk factors (patient comorbidity, microbiological diagnosis, surgical
      intervention, antibiotic treatment, duration of symptoms) on outcome of the patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Change in Oxford Knee Score (Area Under Curve (AUC) from preoperatively to 12 months postoperatively)</measure>
    <time_frame>Measured preoperatively 6 weeks, 3, 6, 9, 12 months postoperatively</time_frame>
    <description>Change in Oxford Knee Score from preoperatively to 12 months postoperatively measured as Area Under Curve. Oxford Knee Score ranges from 0 to 48, 48 = best score.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Oxford Knee Score (Area Under Curve, AUC from preop. to 12 months postop.)</measure>
    <time_frame>Time Frame: Measured preoperatively, 6 weeks, 3, 6, 9, 12, 18 and 24 months postoperatively</time_frame>
    <description>Change in Oxford Knee Score from preoperatively to 24 months postoperatively measured as Area Under Curve. Oxford Knee Score ranges from 0 to 48, 48 = best score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in EuroQol five-dimensional descriptive system (EQ-5D-5L) from preop to 24 months postop.</measure>
    <time_frame>Measured preoperatively, 6 weeks, 3, 6, 9, 12, 18 and 24 months postoperatively.</time_frame>
    <description>Quality of life questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants re-revised (re-revision rate)</measure>
    <time_frame>2 year postoperatively</time_frame>
    <description>Number of patients re-revised due to infection and other causes within 2 years postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants dying (mortality rate)</measure>
    <time_frame>2 years postoperatively</time_frame>
    <description>Number of participants dying within 2 years posoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants readmitted (readmission rate)</measure>
    <time_frame>90 days postoperatively</time_frame>
    <description>Number of participant readmitted within 90 days postoperatively</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Periprosthetic Knee Infection</condition>
  <arm_group>
    <arm_group_label>RIKA cohort</arm_group_label>
    <description>patients with periprosthetic knee joint infection scheduled for revision knee arthroplasty surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>revision surgery</intervention_name>
    <description>The intervention is the planned revision surgery according to local guidelines.</description>
    <arm_group_label>RIKA cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with periprosthetic knee joint infection requiring revision surgery.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical signs of periprosthetic knee joint infection and indication for revision
             surgery

          -  Speak and understand Danish and have given informed consent

        Exclusion Criteria:

          -  Participation in &quot;one-stage versus two-stage revisions of the infected knee
             arthroplasty&quot;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Lindberg-Larsen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Odense University Hospital, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin Lindberg-Larsen, MD, PhD</last_name>
    <phone>0045 25213900</phone>
    <email>martin.lindberg-larsen@rsyd.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aalborg University Hospital</name>
      <address>
        <city>Aalborg</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Kappel, MD</last_name>
      <phone>004520604629</phone>
      <email>andreas.kappel@rn.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jens Bagger, MD</last_name>
      <phone>21603580</phone>
      <email>jens.bagger@regionh.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anders Odgaard, MD, PhD</last_name>
      <phone>0045 27478245</phone>
      <email>anders.odgaard@regionh.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Horsens Hospital</name>
      <address>
        <city>Horsens</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeppe Lange, MD, PhD</last_name>
      <phone>0045 26853290</phone>
      <email>jeppe.lange@clin.au.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Næstved Hospital</name>
      <address>
        <city>Næstved</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henrik Schrøder, MD</last_name>
      <phone>0045 50567163</phone>
      <email>hemsc@regionsjaelland.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Odense Universitets Hospital</name>
      <address>
        <city>Odense</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Lindberg-Larsen, MD, PhD</last_name>
      <phone>0045 25213900</phone>
      <email>martin.lindberg-larsen@rsyd.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vejle Hospital</name>
      <address>
        <city>Vejle</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Bruno Lind-Hansen, MD, PhD</last_name>
      <phone>0045 22289260</phone>
      <email>Thomas.Bruno.Lind-Hansen@rsyd.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <results_reference>
    <citation>Lindberg-Larsen M, Pitter FT, Voldstedlund M, Schrøder HM, Bagger J. Microbiological diagnosis in revision of infected knee arthroplasties in Denmark. Infect Dis (Lond). 2017 Nov - Dec;49(11-12):824-830. doi: 10.1080/23744235.2017.1350878. Epub 2017 Jul 8.</citation>
    <PMID>28691647</PMID>
  </results_reference>
  <results_reference>
    <citation>Lindberg-Larsen M, Jørgensen CC, Bagger J, Schrøder HM, Kehlet H. Revision of infected knee arthroplasties in Denmark. Acta Orthop. 2016 Aug;87(4):333-8. doi: 10.3109/17453674.2016.1148453. Epub 2016 Feb 22.</citation>
    <PMID>26900908</PMID>
  </results_reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>January 8, 2020</study_first_submitted>
  <study_first_submitted_qc>June 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2020</study_first_posted>
  <last_update_submitted>June 10, 2020</last_update_submitted>
  <last_update_submitted_qc>June 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Martin Lindberg-Larsen</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>infection</keyword>
  <keyword>knee arthroplasty</keyword>
  <keyword>surgical treatment</keyword>
  <keyword>patient reported outcome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

